Azorin J-M, Simon N, Adida M, Belzeaux R. Pharmacological treatment of schizophrenia with comorbid substance use disorder. Expert Opinion on Pharmacotherapy. 2015: http://dx.doi.org/10.1517/14656566.2016.1114101
When the above article was first published online, two references have been found to contain typographical errors. These have now been corrected in the print and online version.
Incorrect version
8. Chambers RA, Krystal JH, Self DW. A neurolobiological basis for substance abuse comorbidity in schizophrenia. Biol Psychiatry. 2001;50:71–83.
Correct version
8. Chambers RA, Krystal JH, Self DW. A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol Psychiatry. 2001;50:71–83.
Incorrect version
77. Ralevski E, O’Brien E, Jane S, et al. Treatment with asamprosate in patients with schizophrenia spectrum disorders and comorbid alcohol dependence. J Dual Diagnosis. 2011;7:64–73.
Correct version
77. Ralevski E, O’Brien E, Jane S, et al. Treatment with acamprosate in patients with schizophrenia spectrum disorders and comorbid alcohol dependence. J Dual Diagnosis. 2011;7:64–73.